Annual report
3840.TEDINET S100TX8G
Period2023-04-01 → 2024-03-31
Filed2024-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100UC0G (2024-09-11). Amended by S100X9J7 (2025-12-10).
Key figures · 133
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥2.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥172m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | −¥220m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | −¥168m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥224m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥737m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥538m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥873m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥161m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥253m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥176m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥256m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥746m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥538m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥778m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥176m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | −¥256m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥1.7bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.3bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.1bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.2bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥477m | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥351m | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥470m | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥673m | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥743m | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥297m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥173m | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥297m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥173m | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥345m | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥206m | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥252m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥77m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥352m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥836m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥502m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥346m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥87m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥114m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥24m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥2m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥248m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥288m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥281m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥999m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥454m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥472m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-3.31 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.46 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.95 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.36 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-27.54 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥21.2 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥20.91 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥12.4 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥21.19 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥26.32 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 71.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 46 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 56 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 50 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 50 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 46 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥82m | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥132m | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥95m | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥119m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥35m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥86m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥119m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | −¥132m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥268m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥666m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥341m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥462m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥117m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥298m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | −¥114m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥298m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥1.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥632m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥494m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥946m | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥982m | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.2bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥35m | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥24m | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.1bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥922m | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥334m | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥879m | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.0bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥107m | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥68m | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-2.14 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.36 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-30.54 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.55 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.49 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥19.15 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥17.46 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥8.73 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥27.71 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥36.94 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 96.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.1% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 56,309,516 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 51,509,516 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 36,944,500 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 31,625,800 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,240,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 3 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 4 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 12 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 10 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 3 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥78m |
| Cosmetics Beauty And Wellnes Businessreportable segment | employees | at 2024-03-31 | 28 pure |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.9bn |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.9bn |
| Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥72m |
| Regenerative Medicine Related Businessreportable segment | employees | at 2024-03-31 | 10 pure |
| Regenerative Medicine Related Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥409m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥409m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥36m |
| Sustainable Businessreportable segment | employees | at 2024-03-31 | 5 pure |
| Sustainable Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥42m |
| Sustainable Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥42m |
| Sustainable Businessreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥12,000 |
| Sustainable Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥58m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥2.3bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥2.3bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥12,000 |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | −¥94m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥103m |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥5m |
| Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥64m |
| Regenerative Medicine Related Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥46m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥46m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥9m |
| Sustainable Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥11m |
| Sustainable Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥11m |
| Sustainable Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥200,000 |
| Sustainable Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥62m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥5m |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | −¥117m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,168
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior1YearInstant | 1450158000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 1677657000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 26.32 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 21.19 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 12.40 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 20.91 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 21.20 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | -27.54 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | -18.36 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | -20.95 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -5.46 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | -3.31 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.618 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.629 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.360 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.743 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.712 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | － | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | － | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | － | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | － | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | -345698000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | -502380000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | -835560000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -352396000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | -76610000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | 248498000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | 1930000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -23602000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -113930000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -87374000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -472435000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | 454177000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | 998982000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 281092000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | 287690000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 251928000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 205657000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 345477000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |